Moderna
MRNA
HK$203.59
Share price
-2.09%
Change (1 day)
-74.96%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.
Market capitalization of Moderna (MRNA)
Market cap: HK$78.71 Billion
As of April 2025 Moderna has a market cap of HK$78.71 Billion. This makes Moderna the world's 1616th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Moderna from 2018 to 2025
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2025 | HK$78.71 B | -34.35% |
| 2024 | HK$119.88 B | -59.52% |
| 2023 | HK$296.14 B | -45.07% |
| 2022 | HK$539.16 B | -32.85% |
| 2021 | HK$802.96 B | 150.55% |
| 2020 | HK$320.47 B | 525.11% |
| 2019 | HK$51.26 B | 30.39% |
| 2018 | HK$39.31 B |
End of Day market cap according to different sources
On Apr 15th, 2025 the market cap of Moderna was reported to be:
Market capitalization for similar companies or competitors
| Name | Marketcap | Market cap differencediff. | Country |
|---|---|---|---|
 | HK$1.00 B | -98.73% | 🇺🇸 USA |
 | HK$1.530 T | 1,844.41% | 🇺🇸 USA |
 | HK$6.46 M | -99.99% | 🇺🇸 USA |
 | HK$231.89 B | 194.61% | 🇺🇸 USA |
 | HK$1.693 T | 2,051.65% | 🇨🇭 Switzerland |
 | HK$13.71 B | -82.58% | 🇺🇸 USA |
 | HK$2.872 T | 3,549.10% | 🇺🇸 USA |
 | HK$23.10 B | -70.65% | 🇺🇸 USA |